Christopher M. Coleman

Author

Also Known As

A Rostron, C Coleman, C. Coleman, C. M. Coleman, C.M. Coleman, Christopher Coleman, Christopher M Coleman, Christopher M. Coleman, Christopher Michael Coleman, Coleman, Christopher

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore University of Nottingham Imperial College London University of Oxford University College London

About

Christopher M. Coleman is an author at University of Maryland, Baltimore specializing in medicine, virology, and viral pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	2.3K
2	Engineering	3	3	210
3	Education	2	2	72
4	Allergy	1	1	125
5	Cell Biology	1	1	65

Christopher M. Coleman

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection Julie Dyall, Christopher M. Coleman, Brit J. Hart, Antimicrobial Agents and Chemotherapy Dopamine ReceptorViral DiagnosticsEmerging Infectious DiseasesNeurovirologyPharmacology	2014	695
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Rachael A Evans, Hamish McAuley, Ewen M. Harrison, The Lancet Respiratory Medicine	2021	636
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection Kirsten Kulcsar, Christopher M. Coleman, Sarah E. Beck, JCI Insight Saudi ArabiaDiabetic MiceImmunologyViral PathogenesisImmune Dysregulation	2019	381
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice Christopher M. Coleman, Ye V. Liu, Haiyan Mu, Vaccine VaccinationCross-protectionImmunologyViral PathogenesisVirology	2014	303
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion Christopher M. Coleman, Jeanne M. Sisk, Rebecca M. Mingo, Journal of Virology	2016	273
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 <i>In Vitro</i> and SARS-CoV <i>In Vivo</i> Stuart Weston, Christopher M. Coleman, Robert Haupt, Journal of Virology	2020	232
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection Kristen E. Pascal, Christopher M. Coleman, Alejandro O. Mujica, Proceedings of the National Academy of Sciences Viral DiagnosticsImmunologyViral PathogenesisImmunotherapeuticsTraditional Approaches	2015	219
SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+T-lymphocytes cannot be upregulated by interferons Corine St. Gelais, Suresh de Silva, Sarah M. Amie, Retrovirology	2012	192
Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference Justin Taylor, Christopher M. Coleman, Sandra Postel, Journal of Virology	2015	156

Page 1